CCAAT/enhancer binding proteins (C/EBP) are a family of transcription factors with a highly conserved basic/leucine zipper (bZIP) domain that has been implicated in the transcriptional control of genes involved in cell growth and differentiation. We have previously demonstrated that the expression of C/EBP␣ and C/EBP␤ genes is regulated by thyroid hormone in rat liver during development. The aim of the present study was to explore the molecular mechanisms underlying the control of C/EBP␣ gene expression by thyroid hormone. To achieve this goal, we isolated and characterized a genomic clone containing 1171 bp of the 5Ј-flanking region of the rat C/EBP␣ gene. This fragment was an active promoter in MB492 cells, an immortalized brown adipocyte cell line that expresses the endogenous C/EBP␣ gene in a T 3 -dependent manner. Sequence analysis suggested the presence of three thyroid hormone response elements, TRE-1 (Ϫ602/Ϫ589), TRE2 (Ϫ411/Ϫ396), and TRE3 (Ϫ376/Ϫ350). The results of deletion, mutagenesis, and gel mobility shift analysis disclosed that only TRE-1, an ER2-type response element, represented a functional T 3 response element. Our results demonstrate that T 3 is a factor that positively regulates C/EBP␣ gene expression in a direct fashion. (Endocrinology 141: 4164 -4170, 2000) 
T HE CCAAT/ENHANCER-BINDING proteins are a family of transcription factors that contain a leucine zipper motif required for dimer formation and a basic DNAbinding domain that facilitates interactions between these factors and the regulatory sequences of promoters and/or enhancers of target genes (1, 2) . They are involved in the regulation of cell proliferation, differentiation (3) (4) (5) , and energy metabolism (6) . The C/EBP␣ gene was the first member of the family to be cloned and contains two major in-frame translation start sites and consequently generates two proteins of 42 and 30 kDa (7, 8) . Liver and fat are the major tissues where this gene is expressed, and overexpression of C/EBP␣ in preadipocytes inhibits cell proliferation (5) and activates genes characteristic of differentiated fat cells (3, 9, 10) . Conversely, C/EBP␣ antisense RNA blocks terminal differentiation of preadipocytes, indicating that this gene is essential for adipocyte differentiation (11) . In the liver, the C/EBP␣ protein plays a central role in energy metabolism and regulates the transcription of a number of metabolically important genes, such as 422/aP2, phosphoenolpyruvate carboxykinase (PEPCK), and fatty acid synthase (12) . The important role of C/EBP␣ in fat and liver development is clearly shown in knockout mice. These animals have a major reduction in the lipid content of the fat tissue (6), do not store hepatic glycogen, and die from hypoglycemia within 8 h after birth (6) . Also, studies with primary hepatocytes from these C/EBP␣-deficient mice suggest that this protein influences proliferation, differentiation, and cell survival in liver (6, 13) .
Thyroid hormone (T 3 ) is an important regulator of growth, differentiation, and metabolic processes (14) . The primary site of initiation of T 3 action resides in the nucleus, where the interaction of this hormone with specific nuclear receptors can either enhance or repress the rate of transcription of responsive genes. Thyroid hormone receptors (TRs) are transcription factors that belong to the superfamily of nuclear receptors, which also includes, among others, retinoic acid, steroids, and vitamin D receptors (15) . T 3 receptors are encoded by two distinct genes, TR␣ (NR1A1) and TR␤ (NR1A2). Alternative splicing of the TR␣ primary transcripts at their 3Ј-extremity generates messenger RNAs (mRNAs) encoding TR␣1, which binds T 3 , as well as the variants TR␣2 and TR␣3, which do not. Alternative promoters and splicing generate two T 3 -binding isoforms, TR␤1 and TR␤2 (16) . TR activities are mediated through binding to specific DNA elements, called thyroid hormone response elements (TREs), that are present in the promoter of target genes. They are composed of two hexameric half-sites closely related to the consensus AGGTCA, arranged either as direct repeats or as palindromic or everted (ER) palindromic arrays (17, 18) .
The control of C/EBP␣ gene expression is poorly understood. It is known that C/EBP␣ is developmentally regulated in liver and adipose tissue (19, 20) . Also, C/EBP␣ mRNA has been shown to be regulated by insulin and glucocorticoids in vivo (21, 22) , and more recently we reported the regulation of this gene by thyroid hormone (T 3 ) and retinoic acid during liver development (19) . Therefore, to clarify the mechanism of T 3 regulation of the C/EBP␣ gene, we have isolated, sequenced, and studied the biological activity of a genomic fragment encoding 1171 bp of the 5Ј-flanking region of the C/EBP␣ gene. Our results show that thyroid hormone activates transcription from the C/EBP␣ promoter. Functional analysis by transient transfection of different 5Ј-flanking region fragments as well as gel mobility shift assays and mutagenic analysis suggest that the T 3 effect is mediated through a functional TRE located between nucleotides (nt) Ϫ602 and Ϫ589 (TRE-1), which is an ER2-type response element.
Materials and Methods

Genomic library screening and promoter constructs
A rat genomic library in bacteriophage t10 (Stratagene, La Jolla, CA) was screened with a 32 P-labeled 400-bp fragment of the 5Ј-region of the mouse C/EBP␣ promoter. Duplicate filters were hybridized using standard conditions previously reported (23) . Phage plaques that hybridized positively were identified and plaque-purified by secondary and tertiary screening procedures. Two clones were isolated, and one clone containing a 9.0-kb insert was chosen for further analysis. An approximately 1.2 fragment extending from nt Ϫ1171 to ϩ23 was sequenced by the dideoxynucleotide chain termination method in an Applied Biosystem 377 sequencer (Foster City, CA), amplified by PCR, and subcloned into TA-cloning vector (Invitrogen, Groningan, The Netherlands). The amplified Ϫ1171/ϩ23 fragment was sequenced again to exclude any possible mutation. The 1.2-kb fragment was subcloned in the luciferase reporter vector pXP-1 (pCEBP1171). The 5Ј-deletions of C/EBP␣ promoter, Ϫ689/ϩ23 (pCEBP⌬689), Ϫ587/ϩ23 (pCEBP⌬587), and Ϫ380/ϩ23 (pCEBP⌬380), were generated by PCR and subcloned into the pXP-1-luc vector, and the 3Ј-deletions, Ϫ689/Ϫ290 (pCEBP⌬290) and Ϫ689/Ϫ220 (pCEBP⌬220), were subcloned in the pT109-luc plasmid upstream of the thymidine kinase promoter (Ϫ105/ϩ5).
Point mutations of the TRE-1 site in the Ϫ1171/ϩ23 fragment were created by PCR using the DNA polymerase PfuTurbo following the instructions of the QuickChange site-directed mutagenesis method (Stratagene). The sequences of the oligonucleotides (coding strand) used for mutagenesis are as follows (mutated nucleotides are underlined): MUT1, 5Ј-GTA GTG GGG TCG ATA TCA GTT CAG AGA TAA-3Ј; MUT2, 5Ј-GGG GTC GCC TGG CA GCT GAG ATA AAG ACG-3Ј; MUT3, 5Ј-GTA GTG GGG TCG ATT GGA TAT CAG AGA TAA-3Ј; MUT4, 5Ј-GGG GTC GCC TGT GAG TTC AGA GAT-3Ј; MUT5, 5Ј-GGG TCG CCT GTC GAG TTC AGA GAT-3Ј; MUT6, 5Ј-GGG GTC GCC TGA GTT CAG AGA T-3Ј; and MUT7, 5Ј-TGG GGT CGC CTA GTT CAG AGA T-3Ј.
The PCR product was digested with DpnI, and the DpnI-treated DNA was transformed into DH5␣ competent cells. Plasmids carrying inserts of the appropriate size were sequenced in both directions.
Cell culture and transfections
MB492 cells were maintained in DMEM (Life Technologies, Inc., Grand Island, NY) supplemented with 10% FBS. Semiconfluent cells were transiently transfected using Lipofectamine (Life Technologies, Inc.) according to the manufacturer's guidelines. Briefly, 10 5 cells were plated on 3.5-cm tissue culture dishes in DMEM containing 10% FBS and after 24 h were transfected with the different constructions of the C/EBP␣ promoter. Typically, cells received 2 g luciferase reporter plasmid and 2 g of an internal control plasmid, pCMV␤gal, which contains the gene for ␤-galactosidase enzyme. After 8 h of exposure to the Lipofectamine/DNA mixture, the cells were incubated in complete medium for another 18 h. Cells were then washed, incubated in serumfree medium containing, or not, T 3 (100 nm), and harvested after 24 h for determination of ␤-galactosidase and luciferase activities as previously described (23) . Quantification of luciferase activity was performed with a Berthlod-BioLumat luminometer Beethold GmBH & Co., Bad Wildbad, Germany. Each transient transfection experiment was repeated at least three times in triplicate.
Protein preparation and gel mobility assays
To generate the rat TR␤1, the complementary DNA containing the coding region of this protein was amplified by PCR and subcloned into the BamHI and BglII sites of pQE16, which introduces a histidine tag on the C-terminus (pQE16 vectors; QIAGEN, Hilden, Germany). The histidine-tagged receptor was expressed in the XL1-Blue Escherichia coli strain. After induction for 1.5 h with 0.1 mm isopropylthio-␤-d-galactoside (IPTG), the histidine-tagged TR␤1 was purified. Human RXR␣ protein was generated by expressing pGEX-RXR in NM522 E. coli strain and, after induction with 0.1 mm IPTG, was purified using glutathioneSepharose 4B (Amersham Pharmacia Biotech, Europe, GmbH, Freiburg, Germany). For the binding reactions, 2 g purified TR␤1 and RXR proteins were preincubated for 10 min at room temperature in a buffer containing 15 mm HEPES (pH 8.4), 60 mm KCl, 1 mm EDTA, 1 mm dithiothreitol, 5 mm MgCl 2, 12% glycerol, and 2 g poly(dI-dC) in a total volume of 20 l. After a further 20-min incubation at room temperature in the presence of 60,000 cpm labeled probes, the complexes were separated by electrophoresis on a 5% native polyacrylamide gel. In competition assays, nonradioactive double stranded oligonucleotides were added to the reaction mixture in a 100-fold excess of the radioactive probe. To perform supershift analysis, anti-TR␤1 antibody was added to the reaction mixture and incubated for an additional 15 min. The oligonucleotides used for the assays were as follows (complementary strands are not shown): site TRE-1, 5Ј-GTA GTG GGG TCG CCT GGA GTT CAG AGA TAA-3Ј (Ϫ611/Ϫ582); site TRE-2, 5Ј-CAC GGT AGC TCA AGA CTA ACA TCC TC-3Ј (Ϫ417/Ϫ392); and site TRE-3, 5Ј-CCC CCA ACC TTC ACC TCC CCT TGC TCG GCC TCT GGA TG-3Ј (Ϫ380/Ϫ343).
Northern blot analysis
Total RNA was extracted by homogenization in guanidinium thiocyanate as previously described (24) . Twenty micrograms of RNA were electrophoresed on a 2.2 m formaldehyde/1% agarose gel in 1 ϫ MOPS {20 mm MOPS ϭ (3[N-morpholino]propane-sulfonic acid; 1 mm EDTA; 50 mm sodium acetate; 90 mm NaOH)} buffer at 100 V for 3-4 h and transferred to nylon membranes (Nytran, Renner, Darmstadt, Germany). Labeled C/EBP␣ probe (Ͼ10 8 cpm/g) was generated using random primers and [
32 P]deoxy-CTP (3000 Ci/mmol) and hybridized with the membranes for 20 h at 42 C (50% formamide, 3 ϫ SSC, and 0.2% SDS). The washing conditions were 2 ϫ SSC and 0.5% SDS at 65 C for mild washing and 0.2 ϫ SSC and 0.5% SDS at 65 C for stringent washing. Methylene blue staining of the membranes was used as a loading control. Values in the text are the average quantification of at least three independent experiments corresponding to three different samples.
RT-PCR analysis
Two micrograms of total RNA from MB492 cells were reverse transcribed at 42 C for 1 h with 0.5 g of the corresponding reverse primer and 9 U avian myeloblastosis virus reverse transcriptase (Promega Corp., Madison, WI) in 20 l of the PCR buffer [20 mm Tris-HCl, 16 mm (NH 4 ) 2 SO 4 , 2.5 mm MgCl 2 , and 0.15 mg/ml BSA, pH 8.55]. After inactivation of the reverse transcriptase (65 C, 10 min), PCR was performed using 2 l of the reaction mixture and 2.5 U Taq polymerase (PE Biosystems) for 25 cycles (94 C for 1 min, 55 C for 1 min, 72 C for 2 min, and a final extension at 72 C for 7 min) in a final volume of 50 l. Aliquots of the PCR reaction were analyzed by electrophoresis through 0.8% agarose gel and visualized with ethidium bromide. The oligodeoxynucleotides used for PCR amplification were as follows: rat TR␣1 (forward primer, 5Ј-GAG GAT CCA TGG AAC AGA AGC CAA GCA AG-3Ј; reverse primer, 5Ј-GAA GAT CTG ACT TCC TGA TCC TCA AAG AC-3Ј) that will amplify a fragment of 1200 bp (nt 354-1554) and rat TR␤1 (forward primer, 5Ј-GAA GAT CTA TGA CAG AAA ATC GCC TTC CA-3Ј; reverse primer, 5Ј-GAA GAT CTG TCC TCA AAG ACT TCC AAG AAG-3Ј) that will amplify a fragment of 1300 bp (nt 236-1636).
Statistical analysis
The data were analyzed using the StatWorks software package. Significant effects were determined using Student's t test. A statistically significant difference was considered at P Յ 0.05.
Results
Endogenous C/EBP␣ gene expression is regulated by T 3 in MB492 cells
Regulation of C/EBP␣ gene promoter activity was analyzed in an immortalized brown adipocyte cell line (MB492). This cell line was originally obtained by cotransfection of brown adipocytes obtained from 21-day-old Wistar rat fetuses with immortalizing simian virus 40 large T antigen and pMEXneo. This cell line maintains specific properties of brown adipocytes, such as expression of the uncoupling protein as well as expression of several adipose genes, including the C/EBP family of proteins (25) .
Most of the established cell lines lose their thyroid hormone receptors; therefore, we performed RT-PCR analysis to determine whether MB492 cells express TR␣1 and TR␤1. As shown in Fig. 1A , MB492 cells express appreciable amounts of both isoforms (the identities of the PCR products were confirmed by sequence analysis). The functionality of these receptors was checked by analyzing the effect of T 3 on the expression of the endogenous C/EBP␣ gene. To this end, T 3 was added to the culture medium of MB492 cells, and at different times after hormone addition, cells were harvested and C/EBP␣ mRNA levels were measured by Northern blot analysis. After treatment with 100 nm T 3 for 2 and 24 h, C/EBP␣ mRNA increased 3.5 Ϯ 0.7-and 3.6 Ϯ 0.5-fold, respectively, compared with that in untreated controls (Fig.  1B) . Therefore, this cell line constitutes an excellent model to study the molecular mechanisms implicated in the regulation of the C/EBP␣ gene by thyroid hormone.
Cloning and expression of C/EBP␣ promoter
A 1.2-kb fragment of the 5Ј-flanking promoter region of the C/EBP␣ gene, was cloned by screening a gt10 rat genomic library and was subsequently sequenced bidirectionally by the Sanger method using sequential oligonucleotides as primers. Computer analysis of this 5Ј-flanking sequence revealed several consensus sequences for known regulatory elements, including a TATA box beginning at position Ϫ26, an Sp1 binding site (Ϫ150/Ϫ143), and binding sites for particular transcription factors, such as C/EBP (Ϫ194/Ϫ185), cAMP response element (Ϫ1056/Ϫ1049), nerve growth factor I-A (NGFI-A; Ϫ262/Ϫ254), and Oct-1 (Ϫ790/Ϫ778). This fragment contains also three potential thyroid hormone response elements at nucleotides Ϫ602 to Ϫ589 (TRE-1), Ϫ411 to Ϫ396 (TRE-2), and Ϫ376 to Ϫ350 (TRE-3; Fig. 2) .
To determine the biological activity of C/EBP␣ promoter, several fragments of the C/EBP␣ promoter were cloned upstream of the luciferase reporter gene in the pXP1 vector (constructs pCEBP1171, pCEBP⌬689, pCEBP⌬587, and pCEBP⌬380) or in the pT109 plasmid, containing a minimal promoter of the thymidine kinase (constructs pCEBP⌬290 and pCEBP⌬220), and tested for their expression in MB492 cells. Basal activities are shown in Fig. 3A . Transfection of the pCEBP1171 construct in MB492 cells led to a modest level of luciferase activity (assigned a relative value of 1). Deletion of 482 bp from the 5Ј-end of this fragment resulted in 100-fold enhancement of the activity obtained with the bigger construct, suggesting the removal of a negative element. Deletion of a region between Ϫ689 and Ϫ587 (construct pCEBP⌬587) again reduced the activity slightly, whereas removal of nucleotides between Ϫ587 and Ϫ380 (construct pCEBP⌬380) elevated the basal activity to an extent closely similar to that of the pCEBP⌬689 construct. These data suggest the presence of strong negative and positive cis-elements along the C/EBP␣ gene promoter.
To identify the location of TREs in rat C/EBP␣ promoter, we next analyzed the responses to thyroid hormone of all of these constructs. The results are shown in Fig. 3 , B and C. The fragment Ϫ1171/ϩ23 (construct pCEBP1171) conferred maximal responsiveness to T 3 (3-fold the basal value). The response to T 3 decreased with the plasmid containing the region Ϫ689/ϩ23 (construct pCEBP⌬689). No T 3 stimulation of luciferase activity was observed with constructs pCEBP⌬587 and pCEBP⌬380. The constructs pCEBP⌬290 and pCEBP⌬220 (Fig. 3C ) conferred a 2-fold T 3 inducibility to the thymidine kinase promoter, indicating that the regions Ϫ689/Ϫ290 and Ϫ689/Ϫ220 can confer T 3 responsiveness to a heterologous promoter. All of these data together suggest that the fragment Ϫ689/Ϫ587 is the one that mediates regulation by T 3 , and that sequences downstream or upstream of this fragment are not required for induction by this hormone. These results would rule out a functional role of putative TRE-2 (Ϫ411 to Ϫ396) and TRE-3 (Ϫ376 to Ϫ350) in mediating the regulation of C/EBP␣ gene promoter by T 3 .
Analysis of receptor binding to TRE-1, TRE-2, and TRE-3
To determine whether the three potential response elements of the C/EBP␣ gene were able to bind TR, we performed gel mobility shift assays with recombinant receptors and oligonucleotides containing TRE-1, TRE-2, and TRE-3 sequences, and the complexes formed resolved in a native acrylamide gel. The results presented in Fig. 4 show that TRE-2 and TRE-3 are able to specifically bind TR␤1 receptor; however, these receptors bind to these sites only as monomers. The retarded bands were supershifted by a TR␤1-specific antibody, confirming the presence of this receptor. On the contrary, when RXR was added to the reaction mixture, only TRE-1 was able to specifically bind TR/RXR heterodimers. The retarded bands were competed with unlabeled TRE-containing oligonucleotides. In most of the cases known to date, it is thought that the functional T 3 -responsive element binds TRs as heterodimers with RXR proteins. Therefore, as neither TRE-2 nor TRE-3 was able to bind TR/RXR heterodimers, although they do bind the TR␤1 receptor, these results further suggest that the only functional TRE in the C/EBP␣ promoter is TRE-1.
Mutagenesis analysis
To further confirm our findings about the functional role of TRE-1 in regulating activation of the C/EBP␣ promoter by T 3 , we generated several point mutation, insertion, and deletion constructs, using the QuickChange site-directed mutagenesis (see Materials and Methods) and examined their ability to confer T 3 responsiveness (Fig. 5) . The constructs were then transfected into MB492 cells, and luciferase activity was measured 24 h after addition of T 3 . Mutations in either of the half-sites of TRE-1 totally eliminated C/EBP␣-TRE-1 function (MUT1-MUT3). Addition of one nucleotide (MUT4) or deletion of one (MUT6) or two nucleotides (MUT7) in the spacing region between the half-sites also prevented the 3-fold increase in response to T 3 . However, addition of two nucleotides to this spacing region, and therefore changing the response element to an everted repeat separated by four nucleotides (MUT5, ER4), did not abrogate the response to T 3 of C/EBP␣ promoter. These results combined with the data from the deletion and band-shift analysis indicate that TRE-1 is the functional T 3 -responsive element in this promoter.
Discussion
The results reported here extend our previous findings concerning the regulation by thyroid hormone of C/EBP␣ gene expression in liver. In this paper we show that the C/EBP␣ gene promoter contains a TRE within its 5Ј-flanking region that appears to mediate the induction of C/EBP␣ gene expression by T 3 via interaction with TR/RXR heterodimers.
Our earlier studies showed a complex regulation of C/EBP␣ gene expression by T 3 (19) . Discrepancies in the kinetics of C/EBP␣ transcripts and protein accumulation in response to T 3 in hypothyroid neonates prompted us to postulate a translational and/or posttranslational mechanism of regulation of this gene by thyroid hormone. However, and in contrast to hypothyroid animals, the injection of T 3 to euthyroid neonates elicited a very rapid increase in C/EBP␣ mRNA levels (unpublished results from our laboratory), suggesting the existence of a direct transcriptional mechanism. This possibility is reinforced by the rapid response of the C/EBP␣ gene to T 3 in MB492 cells. Here we have cloned 1171 bp of the C/EBP␣ promoter region and characterized its regulation by thyroid hormone.
First, we studied the basal activity of the C/EBP␣ promoter and, in agreement with Rana et al. (26) , we found that this promoter has strong positive and negative cis-acting elements. The induction of luciferase activity with constructs pCEBP⌬689 and pCEBP⌬380 strongly suggests the existence of two potent silencer elements in the regions Ϫ1171/Ϫ689 and Ϫ587/Ϫ380. In addition, the decrease in luciferase activity obtained with the construct pCEBP⌬587 points to the existence of a strong positive element between Ϫ689 and Ϫ587. The presence of such elements is relatively common in other promoters (27, 28) .
Sequence analysis of the promoter region located between nucleotides Ϫ1171 and ϩ23 revealed the presence of three potential TR-binding sites: TRE-1 (Ϫ602/Ϫ589, TCGCCTggAGT-TCA), which resembles the TR-binding site referred to as an everted repeat with two nucleotides of separation between the two hexamers: TGACCTnnAGGTCA; TRE-2 (Ϫ411/Ϫ396), which resembles a TRE of the type everted repeat with an spacing of three nucleotides; and TRE-3 (Ϫ376/Ϫ350), which is similar to a composite site, containing several core motifs found in the PEPCK promoter (29) . All of our data indicate that only TRE-1 is responsible for the induction of C/EBP␣ gene promoter by T 3 . Serial deletions mapped the boundaries of the The different constructs shown at the left were transiently transfected into MB492 cells, and luciferase assays were performed 24 h after transfections. Data are expressed relative to the values obtained with the bigger fragment (Ϫ1171/ϩ23), and represent the mean Ϯ SD luciferase activity determined in triplicate in at least three independent experiments. B, Identification of DNA regions mediating the regulation by T 3 of C/EBP␣ promoter activity. MB492 cells were transiently transfected with luciferase reporter plasmids containing 5Ј-deletions of the C/EBP␣ promoter, and luciferase activity was determined after 24 h of incubation in the presence or absence of T 3 . Data are expressed relative to the basal value and represent the mean Ϯ SD of luciferase activity determined in triplicate in at least three independent experiments. C, Same as B, but using reporter plasmids containing 3Ј-deletions of the C/EBP␣ promoter linked to a heterologous promoter. *, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001. elements required for T 3 induction of C/EBP␣ promoter activity to the interval between nucleotides Ϫ689 and Ϫ587, and consequently, only the constructs pCEBP1171 and pCEBP⌬689 respond to T 3 in the transfection experiments. Point mutations in either of the half-sites of the palindromic sequence of the TRE-1 abolished trans-activation, indicating that these two modules play a primary role in C/EBP␣-TRE-1 function. Only MUT5, with four nucleotides forming the spacing region, instead of two, was also responsive to T 3 . Gel mobility shift assays demonstrate that the only sequence bound with high affinity by TR/RXR heterodimers is the one that includes the TRE-1 element. This sequence is unable to bind the receptor monomers; this suggests that the heterodimer is the molecular element that mediates thyroid hormone action. To our knowledge, the TRE-1 of the C/EBP␣ gene promoter is the first ER2 proposed as a positive TRE in a native promoter. Previously, ERs with 6 nt of spacing also have been found to be positive TREs in natural promoters such as the promoters of the chicken lysozyme and rat myelin basic protein genes (30, 31) . In the case of the chicken lysozyme promoter, the TRE is part of the core nuclei of a silencer sequence, but, as indicated, this element elicits a positive response to thyroid hormone. Elements of the palindromic type seem to be less common, but synthetic versions of such sites confer potent T 3 responses.
Also, the C/EBP␣ promoter has binding sites for other transcription factors, such as C/EBP (Ϫ194/Ϫ185) and NGFI-A (Ϫ262/Ϫ254), which mediate their actions on this gene (32) (33) (34) . Both transcription factors, C/EBP and NGFI-A, have been shown to interfere with T 3 induction (29, 35, 36) of other genes. Our results showed that the removal of these binding sites (constructs pCEBP⌬290 and pCEBP⌬220) did not affect the inductive effect of T 3 on C/EBP␣ promoter, suggesting that the effect of thyroid hormone is independent of the actions of C/EBP and NGFI-A proteins.
Both factors, C/EBP␣ and thyroid hormone, are involved in the regulation of carbohydrate and lipid metabolism in liver and adipose tissue, mainly through the regulation of genes involved in these processes. C/EBP␣ has been implicated in the transcriptional activation of several genes, such as PEPCK, acetyl-coenzyme A carboxylase, Glut 4, insulin receptor, and Wild-type and mutant promoter constructs were transfected into MB492 cells. Transfection studies were performed as described in Fig. 3 . Data are expressed relative to the basal values and represent the mean Ϯ SD luciferase activity determined in triplicate in at least three independent experiments. **, P Յ 0.01; ***, P Յ 0.001. stearoyl-CoA desaturase 1 (9, 10, 29, 37, 38) . Many of these genes are also regulated by thyroid hormone, such as PEPCK, acetylcoenzyme A carboxylase (38, 39) , and Glut4 (40, 41) . In addition, and as we have commented previously, it has been shown that the C/EBP-binding sites present in the promoters of PEPCK and S14 are required for T 3 stimulation of these genes (29, 35) . Therefore, our findings showing a transcriptional regulation of C/EBP␣ gene by T 3 could represent an important mode of action of thyroid hormone on carbohydrate and lipid metabolism in liver and adipose tissue.
In summary, this report describes a direct transcriptional regulation of C/EBP␣ gene expression by T 3 . This effect requires a TRE that binds TR/RXR heterodimers, is located between nucleotides Ϫ602/Ϫ589, and resembles an everted repeat with two nucleotides of separation (ER2). However, taking into account the results obtained in vivo (19) , nontranscriptional mechanisms cannot be ruled out. Therefore, it seems that in this particular gene, transcriptional and posttranscriptional mechanisms act in concert to amplify the effect of thyroid hormone.
